MOORESTOWN, N.J., Nov. 09, 2016 -- Tabula Rasa HealthCare (NASDAQ:TRHC) Chairman and CEO, Calvin H. Knowlton, Ph.D., has named Janice Casserly Vice President, Human Resources.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c0c1e65b-908a-44a7-adb3-9fd095ac2a13
“We welcome to Tabula Rasa HealthCare Ms. Casserly and her expertise in human resources gained over years of working within private and public companies in a variety of industries,” said Knowlton. “As TRHC enters into the public arena and continues to grow its current business while expanding into new markets, the human resource aspects of the Company become critical for ongoing success. Janice’s knowledge and experience will help keep us ahead of the curve, as we work to accomplish those goals.”
Casserly joins TRHC from Fitch Ratings, Inc., an international agency where she managed all areas of human resources for the Americas. Prior to Fitch Ratings, she was the Managing Director, Human Resources for the American Stock Exchange, New York, NY. Her experience includes research, development and implementation of human resources initiatives, practices and projects through periods of growth, mergers and acquisitions, and changing business demands.
Casserly is a graduate of Rutgers University and was awarded the Juris Doctor from Seton Hall University with a concentration in employment law. She is admitted to the bar in New York and New Jersey.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations. For more information, please visit: www.TRHC.com.
Contact: Media Dianne Semingson [email protected] T: 215-870-0829 Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 [email protected]


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Instagram Outage Disrupts Thousands of U.S. Users
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



